Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas

H Lasolle, C Cortet, F Castinetti, L Cloix… - European Journal of …, 2017 - academic.oup.com
Overall survival and relapse-free survival after the end of TMZ treatment were estimated
using the Kaplan–Meier method. Survival was … Overall survival among responders and non-…

Treatment and long-term outcomes in pituitary carcinoma: a cohort study

F Santos-Pinheiro, M Penas-Prado… - European journal of …, 2019 - academic.oup.com
Pituitary carcinoma (PC) is an aggressive neuroendocrine tumor diagnosed when a pituitary
… The 2, 3 and 5-year survival rate of the entire cohort was 71, 59 and 35%, respectively. All …

Invasive adenoma and pituitary carcinoma: a SEER database analysis

TM Hansen, S Batra, M Lim, GL Gallia, PC Burger… - Neurosurgical …, 2014 - Springer
… In conclusion, pituitary carcinoma patients exhibit worse overall survival than invasive
adenoma patients. This highlights the need for improved diagnostic methods for the sellar phase …

Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment

G Raverot, F Castinetti, E Jouanneau… - Clinical …, 2012 - Wiley Online Library
… The treatment of pituitary carcinomas and aggressive pituitary tumours includes surgery, …
of pituitary carcinomas was mainly palliative and did not seem to increase overall survival. …

[HTML][HTML] … by immune checkpoint inhibitors is associated with better overall survival in both malignant melanoma and non-small cell lung carcinoma: a prospective study

T Kobayashi, S Iwama, Y Yasuda, N Okada… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Original research: Pituitary dysfunction induced by immune checkpoint inhibitors is associated
with better overall survival in both malignant melanoma and non-small cell lung carcinoma

Incidence, demographics, and survival of patients with primary pituitary tumors: a SEER database study in 2004–2016

C Chen, Y Hu, L Lyu, S Yin, Y Yu, S Jiang, P Zhou - Scientific reports, 2021 - nature.com
… relating to the incidence and overall survival of pituitary tumors are still lacking and the …
Only the tumors with documented metastasis were defined as pituitary carcinomas (PCs) and the …

Diagnosis and management of pituitary carcinomas

GA Kaltsas, P Nomikos, G Kontogeorgos… - The Journal of …, 2005 - academic.oup.com
… mean survival in patients with pituitary carcinomas is … carcinomas exhibiting the worst
survival (3, 4, 19, 57–59). Patients with CNS metastases seem to have a more prolonged survival

Temozolomide treatment of pituitary carcinomas and atypical adenomas: systematic review of case reports

Y Ji, RI Vogel, E Lou - Neuro-oncology practice, 2016 - academic.oup.com
… regimen, clinical response, and survival could be identified. The primary goal of this analysis
was to describe overall survival and progression-free survival among PC and APA patients …

Aggressive pituitary tumours and pituitary carcinomas

G Raverot, MD Ilie, H Lasolle, V Amodru… - Nature Reviews …, 2021 - nature.com
… Although usually benign, anterior pituitary tumours occasionally exhibit aggressive … termed
pituitary carcinomas. The time between a ‘classical’ pituitary tumour and a pituitary carcinoma

A population-level analysis of pituitary carcinoma from the National Cancer Database

RM Carey, EC Kuan, AD Workman… - … Surgery Part B: Skull …, 2020 - thieme-connect.com
… Additionally, we describe overall survival (OS) as it relates to tumor behavior and … for overall
survival of patients with pituitary carcinoma based on tumor behavior. OS, overall survival. …